Age-related macular degeneration(AMD) accounts for 8·7% of blindness worldwide and is the most common cause of blindness in developed countries. AMD is a serious cause of vision loss in patients more than 60 years of age. Current article focuses on treatment practices in managing Age- related macular degeneration. Prevalence Its prevalence is likely to increase because of exponential population aging particularly in above 60 years of individuals.
Higher prevalence of the early disease is observed in people of European ancestry than in Asians, and early and late disease onset is observed in people of European ancestry than in those of African ancestry. Pathophysiology The clinical hallmark feature is the presence of drusen. In most cases, drusen are seen bilaterally. Few small hard drusen are not considered as features of macular degeneration but the excess presence of drusen is…
